World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
108
Citations
144505
World Ranking
5849
National Ranking
577

Overview

David R. Matthews is affiliated with the University of Oxford in the United Kingdom. Their primary research focus lies within the field of Medicine, with a significant portion of their work centered on Endocrinology, Diabetes, and Metabolism. Other subfields in which they have contributed include Surgery, Molecular Biology, Pulmonary and Respiratory Medicine, and Genetics.

The scientist's research covers several main topics, notably:

  • Diabetes Treatment and Management
  • Diabetes Management and Research
  • Pancreatic function and diabetes
  • Metabolism, Diabetes, and Cancer
  • Privacy-Preserving Technologies in Data
  • Blockchain Technology Applications and Security
  • Potassium and Related Disorders

Frequent co-authors with whom David R. Matthews has collaborated include:

  • Ioannis Avgerinos
  • Thomas Karagiannis
  • Eleni Bekiari
  • Απόστολος Τσάπας
  • Aris Liakos

David R. Matthews has published extensively in several venues. The most frequent publication outlets consist of:

  • Diabetes Obesity and Metabolism
  • Radiopaedia.org
  • Diabetologia
  • Annals of Internal Medicine
  • Diabetes Therapy

Some of their recent papers include:

  • Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes, 2020, Annals of Internal Medicine
  • Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis, 2022, Diabetologia
  • Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature, 2020, Diabetologia
  • Comparative efficacy of glucose-lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta-analysis, 2021, Diabetes Obesity and Metabolism
  • GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis, 2021, Diabetes Research and Clinical Practice

Best Publications

  • Homeostasis model assessment : insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man

    D. R. Matthews;J. P. Hosker;A. S. Rudenski;B. A. Naylor

  • Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

    Irene M Stratton;Amanda I Adler;H Andrew W Neil;David R Matthews

  • 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

    Rury R. Holman;Sanjoy K. Paul;M. Angelyn Bethel;David R. Matthews

  • Canagliflozin and cardiovascular and renal events in type 2 diabetes

    Bruce Neal;Vlado Perkovic;Vlado Perkovic;Kenneth W. Mahaffey;Dick de Zeeuw

  • Use and Abuse of HOMA Modeling

    Tara M. Wallace;Jonathan C. Levy;David R. Matthews

  • Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Silvio E. Inzucchi;Richard M. Bergenstal;John B. Buse;Michaela Diamant

  • Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Silvio E Inzucchi;Richard M Bergenstal;John B Buse;Michaela Diamant

  • Publication bias in clinical research

    P.J Easterbrook;R Gopalan;J.A Berlin;D.R Matthews

  • Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

    A. I. Adler;I. M. Stratton;H. A. W. Neil;J. S. Yudkin

  • Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

    R C Turner;H Millns;H A W Neil;I M Stratton

  • Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

    Silvio E. Inzucchi;Richard M. Bergenstal;John B. Buse;Michaela Diamant

  • Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program

    Jonathan C Levy;David R Matthews;Michel P Hermans

  • Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study

    Michael Nauck;Anders Frid;Kjeld Hermansen;Nalini S. Shah

  • UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.

    I. M. Stratton;E. M. Kohner;S. J. Aldington;R. C. Turner

  • The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease

    Jill Belch;Angus MacCuish;Iain Campbell;Stuart Cobbe

  • Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study

    Mark Peyrot;R. R. Rubin;T. Lauritzen;F. J. Snoek

  • Sodium–Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes: A Systematic Review and Meta-analysis

    Despoina Vasilakou;Thomas Karagiannis;Eleni Athanasiadou;Maria Mainou

  • Long-term follow-up after tight control of blood pressure in type 2 diabetes

    Rury R. Holman;Sanjoy K. Paul;M. Angelyn Bethel;H. Andrew W. Neil

  • Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility.

    Anubha Mahajan;Min Jin Go;Weihua Zhang;Jennifer E. Below

  • Erratum: Management of hyperglycaemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (Diabetologia (2013) 56 (680))

    S. E. Inzucchi;R. M. Bergenstal;John B Buse;M. Diamant

Frequent Co-Authors

Bruce Neal
Bruce Neal George Institute for Global Health
Vlado Perkovic
Vlado Perkovic George Institute for Global Health
Kenneth W. Mahaffey
Kenneth W. Mahaffey Stanford University
Dick de Zeeuw
Dick de Zeeuw University of Groningen
Rury R. Holman
Rury R. Holman University of Oxford
Michael A. Nauck
Michael A. Nauck Ruhr University Bochum
Silvio E. Inzucchi
Silvio E. Inzucchi Yale University
David B. Dunger
David B. Dunger University of Cambridge
Mark Woodward
Mark Woodward Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in working in healthcare but aren’t sure about attending medical school, there are several online degree options and alternative career pathways to consider. Many students explore direct entry msn programs for non nurses online, which allow individuals without a nursing background to earn a Master of Science in Nursing through flexible, accelerated coursework.

For those seeking accessible pathways into nursing, it’s helpful to review easy nursing programs to get into that offer less competitive admissions, letting more applicants pursue a rewarding nursing career. If you want to avoid high-stakes entrance exams, you can also look for nursing programs without teas requirements, which simplifies the application process.

Not all healthcare roles require direct patient care or clinical duties. For those interested in administrative positions, check out the best medical billing and coding schools online with financial aid. These programs prepare you for well-paid, in-demand roles within the health system.

Best Scientists Citing David R. Matthews

Trending Scientists

Recently Published Articles